Mon, 26-Sep-2022

Melanoma

DermTech Enters into Commercial and Medicare Advanta...

DermTech, Inc. (“DermTech”) announced it has contracted with a regional health plan to make DermTech’s gene expression based Pigmented Lesion Assay (“PLA”) for the early detection of melanoma availab... January 17, 2020 7:28 am By Neha Mule

Related News